ロード中...

Systemic Immunotherapy of Non–Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

Bacillus Calmette-Guerin (BCG) is the standard of care for intravesical therapy for carcinoma in situ and non–muscle invasive, nonmetastatic human urothelial carcinoma. While the responsiveness to this immunotherapeutic is believed to be linked with (i) a high number of somatic mutations and (ii) a...

詳細記述

保存先:
書誌詳細
出版年:Cancer Immunol Res
主要な著者: Vandeveer, Amanda J., Fallon, Jonathan K., Tighe, Robert, Sabzevari, Helen, Schlom, Jeffrey, Greiner, John W.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881865/
https://ncbi.nlm.nih.gov/pubmed/26921031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0176
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!